Monthly trial + 30% off with 6LEET2B. Start · Pricing

StockUpdated May 7, 2026

Is MRK halal?

Merck & Co

Merck & Co (MRK) is included in the current HalalSignalz stock passlist as of May 7, 2026. This is an educational passlist snapshot, not a fatwa, personal financial advice, or a permanent status guarantee.

On HalalSignalz halal stock passlist

Screen: AAOIFI. Category: Healthcare - Big Pharma.

What does Merck & Co do?

Merck develops prescription medicines and vaccines across oncology, infectious disease, cardiometabolic, immunology, and animal health markets.

Halal strength

Positive

Technical

Neutral

Quarterly / fundamental

Neutral

Sentiment

Neutral

Ratings are conservative HalalSignalz snapshot labels from the checked-in passlist. Technical and sentiment labels default to Neutral unless the current snapshot has a stronger reason to flag Watch, Positive, or Weak.

Chart and Market Context

Review live candles, volume, and trend separately from the halal passlist verdict. A ticker can be on the passlist and still be poorly timed, overextended, illiquid, or too volatile for a given portfolio.

View live chart

Company Fundamentals Snapshot

FMP fundamentals add business context for Merck & Co; the HalalSignalz verdict above remains the main value of this page. Use these figures to sanity-check size, profitability, and quality before moving to chart timing or a paid signal.

FMP period: 2026 Q1, 2026-03-31.

Source filing
Quarterly revenue
$16.29B
Gross margin 81.9%.
Quarterly net income
$-4.24B
Net margin -26.0%.
Market cap at data snapshot
$297.36B
P/E ratio
-17.5x
Diluted EPS -1.72 in the same filing period.
Free cash flow yield
1.0%
Return on equity
-9.2%
Current ratio 1.30.

Passlist Snapshot

Business screen
Passlist reviewed
Healthcare - Big Pharma. Source: FMP checked-in deploy snapshot.
Debt / market cap
16.5%
$49.12B interest-bearing debt / $297.36B market cap.
Cash / market cap
1.9%
$5.70B cash and equivalents / $297.36B market cap.
Reported interest income / revenue
0.0%
$0 reported interest income / $16.29B revenue. Proxy only; this is not a full business-line impermissible revenue audit.

Halal Screening Notes

Healthcare - Big Pharma business activity reviewed as part of the current passlist.

Current passlist source: AAOIFI.
Financial ratio fields are held as a curated snapshot and should be rechecked after new quarterly filings.
Dividend purification may apply if the company reports small non-permissible income.

What to Recheck Before Acting

MRK being present on this passlist only answers the first screening question. These are the next checks before treating Merck & Co as investable for your own portfolio.

  • Review the latest 10-Q or 10-K for Merck & Co, especially debt, cash, and interest-income ratios.
  • Confirm Merck & Co's business mix still matches the screened category: Healthcare - Big Pharma.
  • Check valuation, earnings trend, liquidity, and position size separately from the halal screen.

Related Healthcare - Big Pharma Research

Compare MRK with nearby passlist names so the halal screen, business activity, and timing context are not reviewed in isolation.

MRK Halal Screening FAQ

Is MRK halal according to HalalSignalz?
The current HalalSignalz verdict for MRK is: On HalalSignalz halal stock passlist. This May 7, 2026 stock passlist snapshot uses AAOIFI screening context.
Does this stock page mean MRK is a buy?
No. This page is an educational halal-screening snapshot for Merck & Co; investors still need to review valuation, timing, liquidity, risk size, and their own scholar or advisor guidance.
What should be checked before acting on MRK?
Merck & Co should be rechecked against fresh filings, business changes, market conditions, and any purification requirements before making an investment decision.

Continue Research